Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients' tumors, according to early data in a first-in-people clinical trial at Washington University School of Medicine in St. Louis.
from The Medical News http://ift.tt/1aBoXvu
from The Medical News http://ift.tt/1aBoXvu
No comments:
Post a Comment